Gamma-pyrone compounds with selective and potent anti-Helicobacter pylori activity.
Taniguchi
M
M
Lead Discovery Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., Tsukuba-shi, Ibrakaki, Japan.
Watanabe
M
M
Nagai
K
K
Suzumura
K
K
Suzuki
K
K
Tanaka
A
A
D000900:Anti-Bacterial Agents / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology*; D002867:Chromones / Q000737:chemistry / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005285:Fermentation; D005663:Furans / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D006367:HeLa Cells / Q000187:drug effects; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D020128:Inhibitory Concentration 50; D008826:Microbial Sensitivity Tests; D015394:Molecular Structure; D011753:Pyrones / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D013302:Streptomyces / Q000378:metabolism
D000900:Anti-Bacterial Agents; D002867:Chromones; D005663:Furans; C416826:N-acetylaureothamine; D011753:Pyrones; C048200:actinopyrone A; C012198:aureothin